Pharma Marketing Excellence: Lessons from Experience - PowerPoint PPT Presentation

About This Presentation
Title:

Pharma Marketing Excellence: Lessons from Experience

Description:

Marketing excellence. Over the past five years, those two words have been the subject of hype and the focus of management attention. As the pharmaceutical industry struggles with market maturation and weakening product pipelines, marketing excellence programmes have been developed and implemented with an eye to overcoming those hurdles. – PowerPoint PPT presentation

Number of Views:621

less

Transcript and Presenter's Notes

Title: Pharma Marketing Excellence: Lessons from Experience


1
Pharma Marketing Excellence Lessons from
ExperienceMarket Research Reports Distributor
- Aarkstore.com have vast database on market
research reports, company financials, company
profiles, SWOT analysis, company report, company
statistics, strategy review, industry report,
industry research to provide excellent and
innovative service to our report
buyers.Aarkstore.com have very interactive
search feature to browse across more than
2,50,000 business industry reports. We are built
on the premise that reading is valuable, capable
of stirring emotions and firing the imagination.
Whether you're looking for new market research
report product trends or competitive industry
analysis of a new or existing market,
Aarkstore.com has the best resource offerings and
the expertise to make sure you get the right
product every time.
2
Pharma Marketing Excellence Lessons from
Experience
  • Marketing excellence. Over the past five
    years, those two words have been the subject of
    hype and the focus of management attention. As
    the pharmaceutical industry struggles with market
    maturation and weakening product pipelines,
    marketing excellence programmes have been
    developed and implemented with an eye to
    overcoming those hurdles.But how well are they
    working and is there one optimal model for their
    use? There is no question that such programmes
    are costly-even low-cost examples have a high
    'opportunity cost'. In balancing those costs with
    benefit, the past five years have yielded
    important lessons that will now influence the
    future of marketing excellence.
  • Report OverviewIn Pharma Marketing Excellence
    Lessons from Experience, FirstWord reviews the
    role of marketing excellence strategies, what
    they entail and why they have been integrated
    into the wider landscape of competency
    development and marketing strategies. In
    reviewing the experiences of five companies, the
    report reveals a four-archetype model,
    establishes seven key lessons for those
    implementing programmes and offers real solutions
    to not only avoid failure, but ensure success.
  • Key featuresFive cases studies offering
    ground-up insight into marketing excellenceA
    four-archetype model for programmes and clear
    explanation of their best fitSeven key lessons
    for executives implementing marketing
    excellenceExplanation of implications for
    companies considering their implementationOvervi
    ew of what marketing excellence strategies
    involve, their cost and benefits
  • Key BenefitsFull examination of marketing
    excellence, how it works, why it's
    implementedReview of key lessons taken from
    current and past programmesHow companies choose
    programme content and models dependent upon need

3
  • Key Questions AskedWhy do companies invest in
    marketing excellence?How is marketing
    excellence best approached?Is there an optimal
    model?When are marketing excellence programmes
    appropriate?What conditions frame the design of
    marketing excellence strategies?What are the
    real versus targeted outcomes companies have
    experienced?What are the lessons learned from
    past attempts at marketing excellence?
  • Who Should Read This ReportMarketing and Brand
    ManagementCommercial Excellence
    DirectorsMarketing Research/Business
    IntelligenceExecutive ManagementAdvertising/Pr
    omotion
  • Key quotes'Unfortunately, marketing excellence
    is often a reaction to a significant mistake. One
    firm we worked with was driven to develop a
    programme focused on clinical development after a
    product failed approval, which was of course a
    very expensive and avoidable mistake.' Kurt
    Kessler, ZS Associates'Whilst the concepts are,
    in principle, quite simple, the devil is in the
    detail of how it is applied in the context of the
    real world.' Wim Souverijns, Celgene'It is
    about more than just being granted a budget and
    given an objective. The key to success is to have
    the senior management team develop a shared
    vision of the programme.' Theo Nieuwenhuis,
    Boehringer Ingelheim

4
Expert ViewsIan Hartley, Head of
Commercial Excellence, Novartis Oncology Region
EuropeWim Souverijns, Executive Director Global
Marketing Excellence, CelgeneTheo Nieuwenhuis,
Head of Corporate PM Marketing Respiratory/CV,
Boehringer IngelheimBritt Jensen, Vice
President, Global Marketing Commercial
Excellence, Novo NordiskKilian Duffner, SVP
Global Strategic Brand Management,
GrünenthalMartin Lancaster, CEO,
InterCommHoward Godman, Managing Director,
Lansdowne ConsultingKurt Kessler, Managing
Principal, Marketing Solutions, ZS Associates  
5
  •  Lesson 1 Begin with a clear, shared
    vision of the outcome and process Lesson 2
    Allocate appropriate resources Lesson 3 Pick an
    appropriate starting point Lesson 4 Use
    external help appropriately Lesson 5 Apply in
    practice Lesson 6 Develop incrementally Lesson
    7 Measure pragmatically Closing remarks and a
    critique Appendix The Case Companies
  •  
  • Content Highlights Executive
    summary Introduction On the shoulders of
    giants Prior research into marketing
    excellence Why do pharmaceutical companies
    invest in MX programmes?  Implications for
    companies considering marketing excellence What
    do pharmaceutical MX programmes
    involve?  Content scope Organisational
    scope A contingency model of marketing
    excellence programmes Implications for companies
    considering marketing excellence Conclusion What
    have pharmaceutical companies learned from MX
    programmes?

6
  • Related Reports
  • mHealth Market - Global Mobile Health Industry
    Analysis, Size, Share, Growth, Trends and
    Forecast, 2012 - 2018
  • General Medicine Education Publishing Market -
    Global Industry Size, Market Share, Trends,
    Analysis And Forecast, 2012-2018
  • Opioids Market to 2018 - Increasing Concentration
    of Abuse-Resistant Branded Generics Alter
    Competitive Dynamics in this Flat Market
  • Liver Cancer Therapeutics Market to 2018 -
    Nexavar, the Only Approved Targeted Therapy for
    Advanced Disease, Continues to Dominate as Other
    Late Stage Trials Fail
  • Palatin Technologies, Inc. Product Pipeline
    Review 2012
  • Curemark, LLC Product Pipeline Review 2012
  • Lycera Corp. Product Pipeline Review 2012
  • Oncozyme Pharma Inc. Product Pipeline Review
    2012
  • Scancell Holdings Plc Product Pipeline Review
    2012
  • Urigen Pharmaceuticals, Inc. Product Pipeline
    Review 2012

7
  • Contact Us
  • Aarkstore Enterprise
  • Tel 912227453309
  • Mobile No08149852585
  • Email contact_at_aarkstore.com
  • Website http//www.aarkstore.com
  • Blog http//www.emarketreports.com
  • http//teju-aarkstoreenterprise.blogspot.in
  • Follow us on twitter http//twitter.com/aarkstore
    dotcom
  • http//in.linkedin.com/in/aarkstore
  • http//www.facebook.com/aarkstoreenterprise
Write a Comment
User Comments (0)
About PowerShow.com